Chugai Pharmaceutical Co., Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40013097

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

16/12/2021

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%

2015 (année de référence)2030

Description complète des objectifs

Chugai Pharmaceutical Co. , Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 60% by 2030 from a 2019 base year. Chugai Pharmaceutical Co. , Ltd. commits to increase annual sourcing of renewable electricity from 0% in 2019 to 100% by 2025. Chugai Pharmaceutical Co. , Ltd. also commits to reduce absolute scope 3 GHG emissions 30% by 2030 from a 2019 base year.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

ISIN

JP3519400000

LEI

529900T9LAII161DCN95

Source : Science Based Targets initiative | Données publiques